|
Volumn 16, Issue 2, 2009, Pages 4541-4552
|
Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANDROGEN;
PROSTATE SPECIFIC ANTIGEN;
ADENOCARCINOMA;
ADJUVANT THERAPY;
AGED;
ARTICLE;
BLOOD;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
PROSTATE TUMOR;
PROSTATECTOMY;
RADIATION DOSE;
SALVAGE THERAPY;
TREATMENT OUTCOME;
ADENOCARCINOMA;
AGED;
ANDROGEN ANTAGONISTS;
HUMANS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
SALVAGE THERAPY;
TREATMENT OUTCOME;
|
EID: 65649120778
PISSN: 11959479
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|